Sensus Healthcare Inc SRTS.OQ SRTS.O is expected to show a rise in quarterly revenue when it reports results on August 7 for the period ending June 30 2025
The Boca Raton Florida-based company is expected to report a 0.7% increase in revenue to $9.301 million from $9.24 million a year ago, according to the mean estimate from 5 analysts, based on LSEG data.
LSEG's mean analyst estimate for Sensus Healthcare Inc is for earnings of 3 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Sensus Healthcare Inc is $11.00, about 52.3% above its last closing price of $5.25
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2025
0.03
0.03
-0.16
Missed
-570.6
Dec. 31 2025
0.13
0.12
0.09
Missed
-27.4
Sep. 30 2024
0.00
-0.01
0.07
Beat
800
Jun. 30 2024
0.02
0.02
0.10
Beat
328.6
Mar. 31 2024
-0.06
-0.05
0.14
Beat
354.5
Dec. 31 2023
0.14
0.12
0.26
Beat
113.1
Sep. 30 2023
-0.01
-0.02
-0.09
Missed
-400
Jun. 30 2023
-0.08
-0.08
-0.02
Beat
73.7
This summary was machine generated August 5 at 21:52 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)